Skip to Main Content

Paper Details

Mutational Landscape of Secondary Glioblastoma Guides MET-Targeted Trial in Brain Tumor.
Cell
202
2018
-MET (ZM) fusions, Brain Tumor, Low-grade gliomas, MET, MET kinase, MET-altered tumor cells, METex14, PLB-1001, PTPRZ1, Secondary Glioblastoma, TP53, TP53 mutations, ZM, ZM fusion, glioma, gliomas, patients, sGBM, sGBMs, secondary glioblastoma
Author NameAffiliation
Jason K SaInstitute for Refractory Cancer Research, Samsung Medical Center
Hee Jin ChoInstitute for Refractory Cancer Research, Samsung Medical Center
Do-Hyun NamInstitute for Refractory Cancer Research, Samsung Medical Center, Sungkyunkwan University School of Medicine
Do-Hyun NamInstitute for Refractory Cancer Research, Samsung Medical Center, Sungkyunkwan University School of Medicine
Jiguang WangThe Hong Kong University of Science and Technology
  • 1 - 5

Datasets

Release 1.2